![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1537, 2006-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is acute rofecoxib use associated with acute MI?
Reactions Weekly, Vol. 1, Iss. 1101, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
InTIME alters heparin use in acute MI?
Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Combination therapy for acute MI?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Triflusal an alternative to aspirin after acute MI?
Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thrombolysis or transport to angioplasty in acute MI?
Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. :